Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-9-27
pubmed:abstractText
The standard treatment for chronic hepatitis C patients infected with HCV genotype-2 is a combination of pegylated interferon alfa and ribavirin over a 24 week period. It is unclear if a shorter treatment duration is possible for patients showing a rapid virological response (RVR) without compromising the sustained virologic response (SVR) in Korea.
pubmed:commentsCorrections
pubmed:language
kor
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1738-222X
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
341-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17898550-Adolescent, pubmed-meshheading:17898550-Adult, pubmed-meshheading:17898550-Aged, pubmed-meshheading:17898550-Antiviral Agents, pubmed-meshheading:17898550-Data Interpretation, Statistical, pubmed-meshheading:17898550-Drug Therapy, Combination, pubmed-meshheading:17898550-Female, pubmed-meshheading:17898550-Genotype, pubmed-meshheading:17898550-Hepacivirus, pubmed-meshheading:17898550-Hepatitis C, Chronic, pubmed-meshheading:17898550-Humans, pubmed-meshheading:17898550-Interferon-alpha, pubmed-meshheading:17898550-Male, pubmed-meshheading:17898550-Middle Aged, pubmed-meshheading:17898550-Polyethylene Glycols, pubmed-meshheading:17898550-Recombinant Proteins, pubmed-meshheading:17898550-Retrospective Studies, pubmed-meshheading:17898550-Ribavirin, pubmed-meshheading:17898550-Time Factors, pubmed-meshheading:17898550-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
[Short-term therapy with pegylated interferon plus ribavirin for the chronic hepatitis C genotype 2 patients].
pubmed:affiliation
Department of Internal medicine, Inje University College of Medicine, Paik Hospital, Busan, Korea.
pubmed:publicationType
Journal Article, English Abstract